APA (7th ed.) Citation

Yang, T., Chen, H., Bo‐Wen, L., Kim, T. W., Kim, J. G., Ahn, J. B., . . . Park, Y. S. (2023). Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study. Asia Pacific Journal of Clinical Oncology, 19(6), 672. https://doi.org/10.1111/ajco.13920

Chicago Style (17th ed.) Citation

Yang, Tsai‐Sheng, et al. "Prospective, Open‐label, and Observational Study of Cetuximab for Metastatic Colorectal Carcinoma: The OPTIM1SE Study." Asia Pacific Journal of Clinical Oncology 19, no. 6 (2023): 672. https://doi.org/10.1111/ajco.13920.

MLA (9th ed.) Citation

Yang, Tsai‐Sheng, et al. "Prospective, Open‐label, and Observational Study of Cetuximab for Metastatic Colorectal Carcinoma: The OPTIM1SE Study." Asia Pacific Journal of Clinical Oncology, vol. 19, no. 6, 2023, p. 672, https://doi.org/10.1111/ajco.13920.